KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Staar Surgical (STAA) Non-Current Deffered Revenue (2016 - 2026)

Staar Surgical's Non-Current Deffered Revenue history spans 6 years, with the latest figure at $89000.0 for Q1 2026.

For Q1 2026, Non-Current Deffered Revenue changed N/A year-over-year to $89000.0; the TTM value through Jan 2026 reached $89000.0, changed N/A, while the annual FY2026 figure was $89000.0, N/A changed from the prior year.
Non-Current Deffered Revenue reached $89000.0 in Q1 2026 per STAA's latest filing, roughly flat from $89000.0 in the prior quarter.
In the past five years, Non-Current Deffered Revenue ranged from a high of $89000.0 in Q3 2025 to a low of $89000.0 in Q3 2025.